Medtronic has invested nearly $70 million on healthcare training and executed health equity strategies, according to its fiscal year 2021 Integrated Performance Report: Engineering Impact. The report, released Oct. 12, highlights the company's efforts toward environmental, social and governance.
Spinal Tech
The first cases using the 7D Percutaneous Spine Module have been completed in the U.S. and Australia, SeaSpine said Oct. 6.
From leadership moves to technology debuts, here are five key updates from spine and orthopedic device companies in the last week:
ChoiceSpine's Triton sacroiliac joint fixation system received FDA approval, according to an Oct. 5 news release.
Healthcare services company Vizient has awarded Carlsbad, Calif.-based SeaSpine Holdings an innovative technology contract for its 7D Flash Navigation System, SeaSpine said Oct. 4.
Advertisement
Amber Implants' VCFix spinal system for treating vertebral fractures received a breakthrough device designation from the FDA, according to an Oct. 5 news release.
Medical device company MicroPort Orthopedics appointed orthopedic surgeon C. Lowry Barnes, MD, as medical director, according to an Oct. 5 news release.
Two landmark deals from Bioventus and three more acquisitions announced or closed in the third quarter:
Carlsmed's newly launched patient-specific spine implant, Aprevo, has been granted the New Technology Add-On Payment by CMS.
Jeff Cambra, a medtech executive who spent 12 years at Medtronic and most recently worked for Zimmer Biomet, has been appointed CEO of SpinaFX Medical, a Toronto-based minimally invasive image-guided therapy startup.